期刊文献+

辐射诱导溶瘤腺病毒联合放疗对宫颈癌细胞HeLa S3的作用效果 被引量:1

Effect of radiation-induced oncolytic adenovirus combined with chemotherapy on cervical cancer HeLa S3 cells
下载PDF
导出
摘要 目的:构建受辐射诱导的EGR-1启动子调控的携带人TRAIL基因的新型溶瘤腺病毒Ad-EGR-TRAIL,研究其联合放疗对宫颈癌细胞株HeLa S3的杀伤效果。方法:构建重组腺病毒Ad-EGR-TRAIL,用腺病毒Ad-GFP检测对HeLa S3细胞的感染效率。CCK-8法检测Ad-EGR-TRAIL组、单纯放疗组以及Ad-EGR-TRAIL联合放疗组对HeLa S3细胞的杀伤效应,同时观察它们对人正常宫颈细胞的作用。结果:成功构建腺病毒Ad-EGR-TRAIL,当MOI为100时,HeLa S3细胞的腺病毒感染效率最高。单纯Ad-EGR-TRAIL或放疗对HeLa S3细胞增殖的抑制率分别为(8.07±3.02)%和(23.02±4.03)%,Ad-EGR-TRAIL联合放疗对HeLa S3细胞增殖的抑制率达(79.77±9.15)%;同样的处理对正常宫颈细胞无明显抑制作用。结论:Ad-EGR-TRAIL联合放疗对宫颈癌细胞HeLa S3有显著的杀伤作用。 Objective: To construct a new radiation-induced, EGR-1 promotor-regulated, human TRAIL gene containing oncolytic adenovirus Ad-EGR-TRAIL, and to investigate the cytotoxicity effect of Ad-EGR-TRAIL combined with chemotherapy on cervical cancer HeLa S3 cells. Methods: Recombinant adenovirus Ad-EGR-TRAIL was constructed. HeLa S3 cells were infected with Ad-GFP, and infection efficiency was observed. The cytotoxicity effect of Ad- EGRTRAIL, radiotherapy (RAD), and Ad-EGR-TRAIL + RAD on HeLa S3 cells, as well as on normal human cervical ceils, was examined by CCK-8 method. Results: Recombinant adenovirus Ad-EGR-TRAIL was successfully constructed. Ad-EGR-TRAIL showed the highest infection efficiency at MOI = 100 in HeLa S3 cells. The inhibitory rates of HeLa S3 ceils were (8.07± 3.02) % and (23.02 ±4.03 )% when Ad-EGR-TRAIL or RAD was used alone; however, the inhibitory rate reached (79.77±9.15)% when Ad-EGR-TRAIL and RAD were used in combination; and normal cervical cells did not significantly respond to the combination Ad-EGR-TRAIL and RAD therapy. Conclusion: Ad-EGR-TRAIL combined with chemotherapy can significantly kill cervical cancer HeLa S3 cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2011年第6期641-646,共6页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.10979034 No.31071228) 上海市自然科学基金资助项目(No.09ZR1416400)~~
关键词 TRAIL 腺病毒 基因疗法 放射治疗 凋亡 TRAIL adenovirus gene therapy radiotherapy apoptosis
  • 相关文献

参考文献24

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55(2) : 74-108.
  • 2del Carmen MG, McIntyre JF, Goodman A. The role of intraoper- ative radiation therapy (IORT) in the treatment of locally ad- vanced gynecologic malignancies [ J ]. Oncologist, 2000, 5 (1) : 18-25.
  • 3Hockel M, Domhofer N. Treatment of early endometrial carcino- ma: Is less more? [J]. Lancet, 2009, 373(9658) : 97-99.
  • 4Jiang G, Xin Y, Zheng JN, et al. Combining conditionally repli- cating adenovirus-mediated gene therapy with chemotherapy: A novel antitumor approach [J]. Int J Cancer, 2011, 129 (2) : 263 -274.
  • 5Cretney E, Shanker A, Yagita H, et al. TNF-related apoptosis-in- ducing ligand as a therapeutic agent in autoimmunity and cancer [ J ]. Immunol Cell Biol, 2006, 84 ( 1 ) : 87-98.
  • 6Datta R, Rubin E, Sukhatme V, et al. Ionizing radiation activates transcription of the EGR1 gene via CArG elements [ J]. Proc Natl Acad Sci U S A, 1992, 89(21) : 10149-10153.
  • 7Datta R, Taneja N, Sukhatme VP, et al. Reactive oxygen inter- mediates target C C (A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing ra- diation [J]. Proc Natl Acad Sci U S A, 1993, 90(6): 2419- 2422.
  • 8Weiehselbaum RR, Hallahan DE, Beckett MA, et al. Gene thera- py targeted by radiation preferentially radiosensitizes tumor cells [J]. Cancer Res, 1994, 54(16): 4266-4269.
  • 9Yu W, Fang H. Clinical trials with oncolytic adenovirus in China [J]. Curr Cancer Drug Targets, 2007, 7(2) : 141-148.
  • 10Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evi- dence showing that human papillomavirus infection causes most cer- vical intraepithelial neoplasia [ J ]. J Natl Cancer Inst, 1993, 85 (12) : 958-964.

二级参考文献15

  • 1Wagner M, Schmelz K, Dorken B, et al. Transcriptional regulation of human survivin by early growth response (Egr) -1 transcription factor[J]. Int J Cancer, 2008, 122 (6) : 1278-1287.
  • 2Du N, Feng K, Luo C, et al. Radioprotective effect of FLT'3 ligand expression regulated by Egr-1 regulated element on radiation injury of SCID mice[J]. Exp Hematol, 2003, 31 (9) : 191-196.
  • 3Tsurushima H, Yuan X, Dillehay LE, et al. Radiation-inducible caspase-8 gene therapy for malignant brain tumors[ Jl. Int J Radiat Oncol Biol Phys, 2008, 71 (2) : 517-525.
  • 4Lopez CA, Kimchi ET, Mauceri H J, et al. Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity [J]. Mol Cancer Ther, 2004, 3(9): 1167-1175.
  • 5Park JO, Lopez CA, Gupta VK, et al. Transcriptional control of viral gene therapy by eisplatin [ J ]. J Clin Invest, 2002,110 (3) : 403410.
  • 6Waller EK. The role of sargramostim (rhGM-CSF) as immunotherapy [J].Oncologist, 2007, 12 (2) : 22-26.
  • 7Mezhir JJ, Smith KD, Posner MC. Ionizing radiation: a genetic switch for cancer therapy[ J]. Cancer Gene Ther, 2006,13 (1) :1-6.
  • 8Mezhir JJ, Sehmidt H, Yamini B, et al. Chemo-inducible gene therapy [ J ]. Anticancer Drugs, 2005,16 ( 10 ) : 1053-1058.
  • 9Zafarullah M, Li WQ, Sylvester J, et al. Molecular mechanisms of N-acetylcysteine actions[ J]. Cell Mol Life Sci, 2003,60( 1 ): 6-20.
  • 10Bickenbach KA, Veerapong J, Shao MY, et al. Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy [ J ]. Cancer Gene Ther, 2008, 15(3) : 133-139.

同被引文献12

  • 1康保国,王卫东,陈正堂,李德志.放射诱导HSV-TK基因在肺癌细胞中靶向、高效性表达的研究[J].重庆医学,2007,36(6):505-507. 被引量:5
  • 2Shan Y,Lin J,Yan Z,Ding W,et al.Increased expression of activated endothelial nitric oxide synthase contributes to antiandrogen resistance in prostate cancer cells by suppressing androgen receptor transactivation[J].Cancer Letters,2013,9(1):83-94.
  • 3Sabbir U Ahmad,Stuart W A Bergen.A genetic algorithm approach to the inverse problem of treatment planning for intensity-modulated radiotherapy[J].Biomedical Signal Processing and Control,2010,5(3):189-195.
  • 4Dobrila P,Mohammad M,Sanja P.Multi-objective genetic algorithms for scheduling of radiotherapy treatments for categorised cancer patients[J].Expert Systems with Applications,2011,38(6):6994-7002.
  • 5Pierre S,Bénédicte F J,Bernard G,et al.Nitric oxide delivery to cancer:why and how[J] ?European Journal of Cancer,2009,45(8):1352-1369.
  • 6Grant D S,Jyoti N,Elad K,et al.DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions[J].Biochemical Pharmacology,2011,81(2):203-210.
  • 7Prieto C P,Krause C,Quezada B J,et al.Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistribution in human umbilical vein endothelium[J].Placenta,2011,3(12):932-940.
  • 8Lee S K,Kim H S,Lee H J,et al.Dual effect of nitric oxide in immortalized and malignant human oral keratinocytes:induction of apoptosis and differentiation[J].J Oral Pathol Med,2006,35(6):352-360.
  • 9Benjamin B,Stavroula B,Sara H,et al.Novel therapeutic applications of nitric oxide donors in cancer:roles in chemo-and immunosensitization to apoptosis and inhibition of metastases[J].Nitric Oxide,2008,19(2):152-157.
  • 10Wyrobek A J,Manohar C F,Krishnan,et al.Low dose radiation response curves,networks and pathways in human lymphoblastoid cells exposed from 1 to 10 cGy of acute gamma radiation[J].Mutation Research/Genetic Toxicology and Environmental Mutagenesis,2011,72(2):119-130.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部